STOCK TITAN

CRH (NYSE: CRH) secures $2.5B term loan, trims bridge for Arcosa deal

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

CRH public limited company detailed new financing arrangements connected to its planned acquisition of Arcosa, Inc. CRH America Finance, Inc., as borrower, entered into a three-year $2.5 billion Term Loan Facility, which reduced commitments under the previously arranged Bridge Facility to $3.25 billion from $5.75 billion.

Borrowings under the Term Loan Facility will bear interest at the Secured Overnight Financing Rate plus a ratings-based margin, with a quarterly ticking fee on undrawn amounts that steps from 0% to 30% of the applicable margin over time. At closing of the Arcosa merger, Parent expects to use proceeds from the Bridge Facility, the Term Loan Facility and/or alternative financings, together with cash on hand, to satisfy obligations under the Merger Agreement.

Positive

  • None.

Negative

  • None.

Filing Explained

CRH has added committed debt capacity, but replacement funding and Arcosa closing remain unresolved, so the final borrowing mix is not yet fixed.

The July 17 filing leaves the Arcosa financing only partly committed: CRH says replacement financing for some or all of the remaining bridge facility is not committed, while the merger remains subject to stockholder, regulatory and other closing conditions.

That leaves the final funding mix and whether the transaction closes unresolved; the disclosed structural change is financing capacity rather than completed acquisition funding.

The filing describes the term loan as a commitment and refers to the facility’s daily undrawn amount, so it does not establish that the full facility has been borrowed. Any alternative financing would have terms and interest rates dependent on then-current market conditions.

As of March 31, 2026, CRH’s reported cash and equivalents equaled 473.4 days of the last reported operating cash use.

The next material state change is the documentation of any replacement financing and satisfaction of the stated Arcosa merger closing conditions.

Sources and calculations
  • CRH Form 8-K (2026-07-17)
  • CRH 2026 first-quarter fundamentals (2026-03-31)
  • Cash and equivalents vs quarterly operating cash outflow, in days of cash use $3,240,000,000 / ($616,000,000 / 90) = [object Object]
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Term Loan Facility size $2.5 billion Three-year term loan facility commitment for CRH America Finance, Inc.
Original Bridge Facility size $5.75 billion Bridge facility to help fund Arcosa merger, refinance certain Arcosa debt, and pay related costs
Bridge Facility remaining commitments $3.25 billion Remaining commitments after establishment of the $2.5 billion Term Loan Facility
Ticking fee first three months 0% of applicable margin Rate on undrawn Term Loan Facility during first three months after effective date
Ticking fee fourth month 10% of applicable margin Rate on undrawn Term Loan Facility during the fourth month
Ticking fee fifth month 20% of applicable margin Rate on undrawn Term Loan Facility during the fifth month
Ticking fee thereafter 30% of applicable margin Rate on undrawn Term Loan Facility from the sixth month onward
Bridge Facility financial
"entered into a $5.75 billion bridge facility agreement (the ‘Bridge Facility’)"
A bridge facility is a short-term loan or credit line companies use to cover immediate cash needs while they arrange longer-term financing, sell assets, or complete a larger funding deal. Investors care because it temporarily props up a company’s finances and can signal urgent funding gaps; like a bridge that lets traffic keep moving until a permanent road is built, it reduces short-term default risk but may carry higher cost or dilution if extended.
Term Loan Facility financial
"committed to provide a three-year $2.5 billion term loan facility (the ‘Term Loan Facility’)"
A term loan facility is a type of loan provided by a lender that is repaid over a set period of time, usually with fixed payments. It functions like a large, upfront loan that a borrower agrees to pay back gradually, often used to fund major investments or projects. For investors, understanding a company's use of such loans helps assess its financial stability and risk level.
Secured Overnight Financing Rate (SOFR) financial
"Borrowings under the Term Loan Facility bear interest at the Secured Overnight Financing Rate (SOFR)"
A secured overnight financing rate (SOFR) is the interest rate on very short, one‑day loans that are backed by high‑quality collateral (like government bonds), so lenders face less risk. Investors care because SOFR is a widely used benchmark that sets the cost of borrowing and the pricing of loans, bonds and derivatives; think of it as a trusted yardstick for short‑term interest costs that influences returns and valuations across markets.
ticking fee financial
"A ticking fee is payable on a quarterly basis based on a percentage"
A ticking fee is a charge that accrues over time when one party has committed to a deal but the transaction has not yet closed; it compensates the other side for the cost and risk of the delay. For investors, it matters because it raises the effective cost of a transaction and signals how long completion may take—like paying a small ongoing rent while waiting for a house sale to finish, which can affect returns and deal judgment.
ratings-based pricing grid financial
"plus a margin determined in accordance with a ratings-based pricing grid"
forward-looking statements regulatory
"contains statements that are, or may be deemed to be, forward-looking statements"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What new financing did CRH (CRH) arrange for the Arcosa acquisition?

CRH arranged a three-year $2.5 billion Term Loan Facility for CRH America Finance, Inc. This term loan will help fund the Arcosa merger consideration, refinance certain Arcosa debt, and cover related fees and expenses alongside existing and potential alternative financings.

How does the new term loan affect CRH (CRH)’s existing Bridge Facility?

The new term loan reduced commitments under CRH’s existing Bridge Facility to $3.25 billion from $5.75 billion. The Bridge Facility was established to help fund the Arcosa merger and refinance Arcosa’s debt, and may be further replaced by alternative financings.

What interest terms apply to CRH (CRH)’s $2.5 billion Term Loan Facility?

Borrowings under the Term Loan Facility bear interest at SOFR plus a ratings-based margin. Undrawn amounts incur a quarterly ticking fee calculated as a percentage of that margin, with the percentage increasing over time after the facility’s effective date.

How is the ticking fee on CRH (CRH)’s Term Loan Facility structured?

The ticking fee on undrawn amounts is 0% of the applicable margin for the first three months, then 10% in the fourth month, 20% in the fifth month, and 30% thereafter. It is calculated quarterly on the daily undrawn portion of the facility.

How does CRH (CRH) plan to fund obligations under the Arcosa Merger Agreement?

At closing, Parent expects to use proceeds from the Bridge Facility, the $2.5 billion Term Loan Facility and/or alternative financings, together with cash on hand, to pay obligations under the Arcosa Merger Agreement, subject to satisfaction of the agreed conditions.

Are CRH (CRH)’s planned alternative financings for the Arcosa deal committed?

The alternative financings are not committed. CRH expects to replace some or all remaining Bridge Facility commitments with such financings, whose final terms and interest rates will depend on market conditions and may or may not be consummated.
false000084939500008493952026-07-172026-07-170000849395us-gaap:CommonStockMember2026-07-172026-07-170000849395crh:FivePointTwoPercentGuaranteedNotesDue2029Member2026-07-172026-07-170000849395crh:FivePointOneTwoFivePercentGuaranteedNotesDue2030Member2026-07-172026-07-170000849395crh:FourPointFourPercentGuaranteedNotesDue2031Member2026-07-172026-07-170000849395crh:SixPointFourPercentNotesDue2033Member2026-07-172026-07-170000849395crh:FivePointFourPercentGuaranteedNotesDue2034Member2026-07-172026-07-170000849395crh:FivePointFivePercentGuaranteedNotesDue2035Member2026-07-172026-07-170000849395crh:FivePercentGuaranteedNotesDue2036Member2026-07-172026-07-170000849395crh:FivePointEightSevenFivePercentGuaranteedNotesDue2055Member2026-07-172026-07-170000849395crh:FivePointSixPercentGuaranteedNotesDue2056Member2026-07-172026-07-17


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 17, 2026

CRH-Logo-FullColour-RGB.jpg
CRH public limited company
(Exact name of registrant as specified in its charter)
Ireland001-3284698-0366809
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
Stonemason's Way, Rathfarnham,
Dublin 16, D16 KH51, Ireland
(Address of principal executive offices)
+353 1 404 1000
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d 2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))











Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Ordinary Shares of €0.32 eachCRHNew York Stock Exchange
5.200% Guaranteed Notes due 2029CRH/29New York Stock Exchange
5.125% Guaranteed Notes due 2030CRH/30New York Stock Exchange
4.400% Guaranteed Notes due 2031CRH/31New York Stock Exchange
6.400% Notes due 2033CRH/33ANew York Stock Exchange
5.400% Guaranteed Notes due 2034CRH/34New York Stock Exchange
5.500% Guaranteed Notes due 2035CRH/35New York Stock Exchange
5.000% Guaranteed Notes due 2036CRH/36New York Stock Exchange
5.875% Guaranteed Notes due 2055CRH/55New York Stock Exchange
5.600% Guaranteed Notes due 2056CRH/56New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Item 8.01    Other Events.
As previously announced in CRH public limited company’s (‘CRH’) Current Report on Form 8-K filed with the Securities and Exchange Commission on June 22, 2026, CRH Americas, Inc. (‘Parent’), a Delaware corporation and indirect wholly owned subsidiary of CRH, Neon Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (‘Merger Sub’), and Arcosa, Inc., a Delaware corporation (‘Arcosa’), entered into an Agreement and Plan of Merger (the ‘Merger Agreement’), pursuant to which, subject to the terms and conditions set forth therein, Merger Sub will merge with and into Arcosa, with Arcosa being the surviving entity and becoming a wholly owned subsidiary of Parent (the ‘Merger’).

Also as previously announced on June 22, 2026, in connection and substantially concurrently with the Merger Agreement, CRH, as guarantor, and CRH America Finance, Inc., a Delaware corporation and indirect wholly owned subsidiary of CRH (‘America Finance’), as borrower, entered into a $5.75 billion bridge facility agreement (the ‘Bridge Facility’) with the lenders party thereto, under which the amounts borrowed may be used to pay, in part, the consideration payable under the Merger Agreement, the refinancing of certain of Arcosa’s existing debt and fees and expenses related to the Merger.

On July 17, 2026, CRH, as guarantor, and America Finance, as borrower, entered into a term loan facility agreement with the lenders party thereto, pursuant to which such lenders committed to provide a three-year $2.5 billion term loan facility (the ‘Term Loan Facility’). As a result of the Term Loan Facility, the commitments under the Bridge Facility were reduced to $3.25 billion. Borrowings under the Term Loan Facility bear interest at the Secured Overnight Financing Rate (SOFR) plus a margin determined in accordance with a ratings-based pricing grid. A ticking fee is payable on a quarterly basis based on a percentage of the applicable margin and calculated on the daily undrawn amount of the Term Loan Facility. The ticking fee rate is (i) 0% of applicable margin during the first three months after the effective date of the Term Loan Facility, (ii) 10% of applicable margin during the fourth month, (iii) 20% of applicable margin during the fifth month and (iv) 30% of applicable margin thereafter. The Term Loan Facility includes customary terms and conditions for investment-grade borrowers. There are no financial covenants. The availability of the loans under the Term Loan Facility is subject to the same conditions as the conditions under the Bridge Facility.







CRH expects to replace some or all of the remaining commitments under the Bridge Facility with one or more alternative financings prior to closing of the Merger. CRH anticipates that the definitive documentation governing such alternative financings will contain customary covenants for financing transactions of a similar nature and will carry an interest rate based on then current market conditions. The terms of such alternative financings are not committed, and the exact terms and interest rate of such financings will be subject to market conditions. There can be no assurance regarding if or when such alternative financings will be consummated or the terms of such financings. At closing, Parent expects to use the proceeds of the loans under the Bridge Facility and the Term Loan Facility (and/or such alternative financing), together with cash on hand, to pay its obligations in respect of the Merger Agreement.



Forward-Looking Statements

This Current Report on Form 8-K (this ‘Current Report’) contains statements that are, or may be deemed to be, forward-looking statements with respect to the Merger, including the proposed financing for the Merger and the use of proceeds therefrom. These forward-looking statements may generally, but not always, be identified by the use of words such as “will”, “anticipates”, “should”, “could”, “would”, “targets”, “aims”, “may”, “continues”, “expects”, “is expected to”, “estimates”, “believes”, “intends” or similar expressions. These forward-looking statements include all matters that are not historical facts or matters of fact at the date of this Current Report.

By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future and reflect CRH’s current expectations and assumptions as to such future events and circumstances that may not prove accurate. You are cautioned not to place undue reliance on any forward-looking statements. These forward-looking statements are made as of the date of this Current Report. CRH expressly disclaims any obligation or undertaking to publicly update or revise these forward-looking statements other than as required by applicable law.

A number of material factors could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements, certain of which are beyond our control, and which include, but are not limited to: the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger Agreement; the failure to obtain the required approval of Arcosa’s stockholders; the failure to satisfy the other conditions to the completion of the Merger, including the receipt of required regulatory approvals; risks that the Merger disrupts CRH’s current plans and operations; the ability to recognize the anticipated benefits of the Merger; the amount of costs, fees, expenses and charges related to the Merger and the actual terms of the financing obtained in connection with the Merger; diversion of management’s attention from ongoing business operations and opportunities; potential litigation relating to the Merger; the effect of the pendency of the Merger on CRH’s and Arcosa’s business relationships, operating results and business generally; economic and financial conditions, including changes in interest rates, inflation, price volatility and/or labor and materials shortages; and the risks and uncertainties described under “Risk Factors” in Part I, Item 1A in CRH’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 as filed with the SEC and in CRH’s other filings with the SEC.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 17, 2026
CRH plc
/s/ Aylwyn Bryan
By:Aylwyn Bryan
Chief Financial Officer

Filing Exhibits & Attachments

4 documents